This difference in lymphocytes between WT and MFS may be explained by enhanced (local) transforming growth factor beta (TGFβ) levels in MFS patients and mice (39, 40) since TGFβ is involved in immune cell development and activation (41). The gene discussed is TGFB1; the disease is Marfan syndrome.